ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	10/78	157/7206	6.37796884012e-06
ko05164	Influenza A	10/78	167/7206	1.10376571598e-05
ko04060	Cytokine-cytokine receptor interaction	10/78	191/7206	3.55372532944e-05
ko04217	Necroptosis	9/78	178/7206	0.000117690678975
ko05152	Tuberculosis	9/78	187/7206	0.000171350410735
ko04668	TNF signaling pathway	7/78	120/7206	0.000296105109779
ko05145	Toxoplasmosis	7/78	126/7206	0.000399044377251
ko04064	NF-kappa B signaling pathway	6/78	96/7206	0.000566815611044
ko04672	Intestinal immune network for IgA production	4/78	37/7206	0.000639800572323
ko04620	Toll-like receptor signaling pathway	6/78	100/7206	0.000704346227079
ko05167	Kaposi's sarcoma-associated herpesvirus infection	8/78	191/7206	0.00100875080093
ko04612	Antigen processing and presentation	5/78	77/7206	0.00140469590009
ko05330	Allograft rejection	3/78	24/7206	0.00209656665717
ko04630	Jak-STAT signaling pathway	6/78	132/7206	0.0029442972951
ko05321	Inflammatory bowel disease (IBD)	4/78	56/7206	0.00304659371861
ko04380	Osteoclast differentiation	6/78	134/7206	0.0031734204931
ko04210	Apoptosis	7/78	180/7206	0.00320286143062
ko05320	Autoimmune thyroid disease	3/78	29/7206	0.00364091423526
ko04650	Natural killer cell mediated cytotoxicity	5/78	97/7206	0.00387471987018
ko05340	Primary immunodeficiency	3/78	30/7206	0.00401422046703
ko05160	Hepatitis C	6/78	153/7206	0.00606822639813
ko01524	Platinum drug resistance	4/78	76/7206	0.00904605353974
ko05162	Measles	5/78	120/7206	0.00945638599013
ko05161	Hepatitis B	6/78	173/7206	0.0108275562815
ko05230	Central carbon metabolism in cancer	4/78	81/7206	0.0112654718055
ko05212	Pancreatic cancer	4/78	83/7206	0.0122432353916
ko05168	Herpes simplex infection	6/78	182/7206	0.0136610794596
ko05332	Graft-versus-host disease	2/78	18/7206	0.0158196188847
ko04919	Thyroid hormone signaling pathway	5/78	143/7206	0.0190302272726
ko04062	Chemokine signaling pathway	6/78	201/7206	0.0212788328106
ko04142	Lysosome	5/78	151/7206	0.0234698965846
ko04071	Sphingolipid signaling pathway	5/78	162/7206	0.0305987322863
ko05215	Prostate cancer	4/78	111/7206	0.0318511740975
ko05014	Amyotrophic lateral sclerosis (ALS)	3/78	74/7206	0.0457340537372
ko04940	Type I diabetes mellitus	2/78	32/7206	0.0465423059572
ko04932	Non-alcoholic fatty liver disease (NAFLD)	5/78	182/7206	0.0467673196476
ko05140	Leishmaniasis	3/78	75/7206	0.0472796535192